دورية أكاديمية

Microbiome diversity in carriers of fluoroquinolone resistant Escherichia coli .

التفاصيل البيبلوغرافية
العنوان: Microbiome diversity in carriers of fluoroquinolone resistant Escherichia coli .
المؤلفون: Liss MA; Department of Urology, UT Health San Antonio Long School of Medicine, San Antonio, TX, USA.; South Texas Veterans Healthcare System, San Antonio, TX, USA., Leach RJ; Department of Urology, UT Health San Antonio Long School of Medicine, San Antonio, TX, USA.; Department of Cell Systems and Anatomy, UT Health San Antonio Long School of Medicine, San Antonio, TX, USA., Rourke E; Department of Urology, UT Health San Antonio Long School of Medicine, San Antonio, TX, USA., Sherrill A; Department of Urology, UT Health San Antonio Long School of Medicine, San Antonio, TX, USA., Johnson-Pais T; Department of Urology, UT Health San Antonio Long School of Medicine, San Antonio, TX, USA.; Department of Cell Systems and Anatomy, UT Health San Antonio Long School of Medicine, San Antonio, TX, USA., Lai Z; Genome Sequencing Facility (GSF) in the Greehey Children's Cancer Research Institute (Greehey CCRI), San Antonio, TX, USA., Basler J; Department of Urology, UT Health San Antonio Long School of Medicine, San Antonio, TX, USA., White JR; Resphera Biosciences, San Antonio, TX, USA., Patterson JE; Department of Medicine, UT Health San Antonio Long School of Medicine, San Antonio, TX, USA.
المصدر: Investigative and clinical urology [Investig Clin Urol] 2019 Mar; Vol. 60 (2), pp. 75-83. Date of Electronic Publication: 2019 Feb 27.
نوع المنشور: Journal Article; Observational Study; Research Support, N.I.H., Extramural
اللغة: English
بيانات الدورية: Publisher: Korean Urological Association Country of Publication: Korea (South) NLM ID: 101674989 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2466-054X (Electronic) Linking ISSN: 24660493 NLM ISO Abbreviation: Investig Clin Urol Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Seoul : Korean Urological Association, [2016]-
مواضيع طبية MeSH: Gastrointestinal Microbiome*, Escherichia coli/*drug effects , Escherichia coli/*isolation & purification , Fluoroquinolones/*pharmacology , Rectum/*microbiology, Aged ; Carrier State ; Drug Resistance, Bacterial ; Escherichia coli Infections/microbiology ; Humans ; Male ; Middle Aged
مستخلص: Purpose: Fluoroquinolone-resistant (FQR) Escherichia coli causes transrectal prostate biopsy infections. In order to reduce colonization of these bacteria in carriers, we would like to understand the surrounding microbiome to determine targets for decolonization.
Materials and Methods: We perform an observational study to investigate the microbiome differences in men with and without FQR organisms found on rectal culture. A rectal swab with two culturettes was performed on men before an upcoming prostate biopsy procedure as standard of care to perform "targeted prophylaxis." Detection of FQR was performed by the standard microbiology lab inoculates the swab onto MacConkey agar containing ciprofloxacin. The extra swab was sent for 16S rRNA amplicon sequencing (MiSeq paired-end) using the V1V2 primer. Alpha and beta-diversity analysis were performed using QIIME. We used PERMANOVA to evaluate the statistical significance of beta-diversity distances within and between groups of interest.
Results: We collected 116 rectal swab samples before biopsy for 16S rRNA amplicon sequencing. We identified 18 isolates (15.5%, 18/116) that were positive and had relative reduced diversity profiles (p<0.05). Enterobacteriaceae were significantly over-represented in the FQR subjects (adjusted p=0.03).
Conclusions: Microbiome analysis determined that men colonized with FQR bacteria have less diverse bacterial communities (dysbiosis), higher levels of Enterobacteriaceae and reduced levels of Prevotella disiens . These results may have implications in pre/probiotic intervention studies.
Competing Interests: CONFLICTS OF INTEREST: Resphera Biosciences was paid to perform the microbiome analysis, and Dr. White is the owner of the company.
References: J Urol. 2014 Dec;192(6):1673-8. (PMID: 24928266)
Proc Natl Acad Sci U S A. 1998 Jul 21;95(15):8922-6. (PMID: 9671780)
Nature. 2010 Mar 4;464(7285):59-65. (PMID: 20203603)
PLoS One. 2013 Dec 31;8(12):e83823. (PMID: 24391833)
Int J Mol Sci. 2018 Nov 22;19(12):. (PMID: 30469463)
ILAR J. 2015;56(2):205-17. (PMID: 26323630)
Nature. 2017 Jun 22;546(7659):528-532. (PMID: 28614296)
PLoS Biol. 2012;10(8):e1001377. (PMID: 22904687)
PLoS One. 2014 Jul 14;9(7):e101344. (PMID: 25020051)
Proc Natl Acad Sci U S A. 1995 Mar 14;92(6):2081-5. (PMID: 7892228)
Bioinformatics. 2010 Jan 15;26(2):266-7. (PMID: 19914921)
Nature. 2011 May 12;473(7346):174-80. (PMID: 21508958)
Clin Infect Dis. 2013 Jul;57(2):267-74. (PMID: 23532481)
J Urol. 2012 Apr;187(4):1275-9. (PMID: 22341272)
Nat Med. 2013 May;19(5):576-85. (PMID: 23563705)
J Urol. 2011 Nov;186(5):1830-4. (PMID: 21944136)
Nature. 2012 Jun 13;486(7402):207-14. (PMID: 22699609)
PLoS One. 2017 Jan 27;12(1):e0170742. (PMID: 28129384)
Front Microbiol. 2013 Apr 17;4:87. (PMID: 23616784)
Nature. 2012 Jun 13;486(7402):215-21. (PMID: 22699610)
mBio. 2014 Jan 07;5(1):e00944-13. (PMID: 24399857)
ISME J. 2012 Mar;6(3):610-8. (PMID: 22134646)
PLoS One. 2012;7(6):e39315. (PMID: 22720093)
Behav Brain Res. 2001 Nov 1;125(1-2):279-84. (PMID: 11682119)
Bioinformatics. 2011 Nov 1;27(21):2957-63. (PMID: 21903629)
Clin Infect Dis. 2015 Apr 1;60(7):979-87. (PMID: 25516194)
Int J Antimicrob Agents. 2014 Apr;43(4):301-9. (PMID: 24630305)
Microbiome. 2018 Apr 20;6(1):73. (PMID: 29678198)
Proc Natl Acad Sci U S A. 1996 Sep 3;93(18):9827-32. (PMID: 8790416)
معلومات مُعتمدة: UM1 AI104681 United States AI NIAID NIH HHS
فهرسة مساهمة: Keywords: Anti-bacterial agents; Escherichia coli; Infection; Microbiota; Prostate
المشرفين على المادة: 0 (Fluoroquinolones)
تواريخ الأحداث: Date Created: 20190307 Date Completed: 20200109 Latest Revision: 20200309
رمز التحديث: 20240829
مُعرف محوري في PubMed: PMC6397931
DOI: 10.4111/icu.2019.60.2.75
PMID: 30838339
قاعدة البيانات: MEDLINE
الوصف
تدمد:2466-054X
DOI:10.4111/icu.2019.60.2.75